TY - JOUR
T1 - Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS
AU - on behalf of the COVID-19 Spanish ICU Network
AU - Ferrando, Carlos
AU - Suarez-Sipmann, Fernando
AU - Mellado-Artigas, Ricard
AU - Hernández, María
AU - Gea, Alfredo
AU - Arruti, Egoitz
AU - Aldecoa, César
AU - Martínez-Pallí, Graciela
AU - Martínez-González, Miguel A.
AU - Slutsky, Arthur S.
AU - Villar, Jesús
AU - Ferrando, Carlos
AU - Martínez-Pallí, Graciela
AU - Mercadal, Jordi
AU - Muñoz, Guido
AU - Mellado, Ricard
AU - Jacas, Adriana
AU - Vendrell, Marina
AU - Sánchez-Etayo, Gerard
AU - Alcón, Amalia
AU - Belda, Isabel
AU - Agustí, Mercé
AU - Carramiñana, Albert
AU - Gracia, Isabel
AU - Panzeri, Miriam
AU - León, Irene
AU - Balust, Jaume
AU - Navarro, Ricard
AU - Arguís, María José
AU - Carretero, Maria José
AU - Ibáñez, Cristina
AU - Perdomo, Juan
AU - López, Antonio
AU - López, Manuel
AU - Cuñat, Tomás
AU - Ubré, Marta
AU - Ojeda, Antonio
AU - Calvo, Andrea
AU - Rivas, Eva
AU - Hurtado, Paola
AU - Pujol, Roger
AU - Martín, Nuria
AU - Tercero, Javier
AU - Sanahuja, Pepe
AU - Magaldi, Marta
AU - Coca, Miquel
AU - del Rio, Elena
AU - Martínez-Ocon, Julia
AU - Masgoret, Paula
AU - Caballero, Angel
N1 - Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2020/12
Y1 - 2020/12
N2 - Purpose: The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV). Methods: This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS (as defined by the Berlin criteria) affected with with COVID-19 (confirmed SARS-CoV-2 infection in nasal or pharyngeal swab specimens), admitted to a network of 36 Spanish and Andorran intensive care units (ICUs) between March 12 and June 1, 2020. We examined the clinical features, ventilatory management, and clinical outcomes of COVID-19 ARDS patients, and compared some results with other relevant studies in non-COVID-19 ARDS patients. Results: A total of 742 patients were analysed with complete 28-day outcome data: 128 (17.1%) with mild, 331 (44.6%) with moderate, and 283 (38.1%) with severe ARDS. At baseline, defined as the first day on invasive MV, median (IQR) values were: tidal volume 6.9 (6.3–7.8) ml/kg predicted body weight, positive end-expiratory pressure 12 (11–14) cmH2O. Values of respiratory system compliance 35 (27–45) ml/cmH2O, plateau pressure 25 (22–29) cmH2O, and driving pressure 12 (10–16) cmH2O were similar to values from non-COVID-19 ARDS patients observed in other studies. Recruitment maneuvers, prone position and neuromuscular blocking agents were used in 79%, 76% and 72% of patients, respectively. The risk of 28-day mortality was lower in mild ARDS [hazard ratio (RR) 0.56 (95% CI 0.33–0.93), p = 0.026] and moderate ARDS [hazard ratio (RR) 0.69 (95% CI 0.47–0.97), p = 0.035] when compared to severe ARDS. The 28-day mortality was similar to other observational studies in non-COVID-19 ARDS patients. Conclusions: In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.
AB - Purpose: The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known. We describe characteristics and outcomes of confirmed ARDS in COVID-19 patients managed with invasive mechanical ventilation (MV). Methods: This is a multicenter, prospective, observational study in consecutive, mechanically ventilated patients with ARDS (as defined by the Berlin criteria) affected with with COVID-19 (confirmed SARS-CoV-2 infection in nasal or pharyngeal swab specimens), admitted to a network of 36 Spanish and Andorran intensive care units (ICUs) between March 12 and June 1, 2020. We examined the clinical features, ventilatory management, and clinical outcomes of COVID-19 ARDS patients, and compared some results with other relevant studies in non-COVID-19 ARDS patients. Results: A total of 742 patients were analysed with complete 28-day outcome data: 128 (17.1%) with mild, 331 (44.6%) with moderate, and 283 (38.1%) with severe ARDS. At baseline, defined as the first day on invasive MV, median (IQR) values were: tidal volume 6.9 (6.3–7.8) ml/kg predicted body weight, positive end-expiratory pressure 12 (11–14) cmH2O. Values of respiratory system compliance 35 (27–45) ml/cmH2O, plateau pressure 25 (22–29) cmH2O, and driving pressure 12 (10–16) cmH2O were similar to values from non-COVID-19 ARDS patients observed in other studies. Recruitment maneuvers, prone position and neuromuscular blocking agents were used in 79%, 76% and 72% of patients, respectively. The risk of 28-day mortality was lower in mild ARDS [hazard ratio (RR) 0.56 (95% CI 0.33–0.93), p = 0.026] and moderate ARDS [hazard ratio (RR) 0.69 (95% CI 0.47–0.97), p = 0.035] when compared to severe ARDS. The 28-day mortality was similar to other observational studies in non-COVID-19 ARDS patients. Conclusions: In this large series, COVID-19 ARDS patients have features similar to other causes of ARDS, compliance with lung-protective ventilation was high, and the risk of 28-day mortality increased with the degree of ARDS severity.
KW - Acute respiratory distress syndrome
KW - Coronavirus
KW - Mechanical ventilation
KW - Outcome
UR - https://www.scopus.com/pages/publications/85089861956
U2 - 10.1007/s00134-020-06192-2
DO - 10.1007/s00134-020-06192-2
M3 - Article
C2 - 32728965
AN - SCOPUS:85089861956
SN - 0342-4642
VL - 46
SP - 2200
EP - 2211
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 12
ER -